Apheresis Market Share 2026

Apheresis is a medical procedure that involves removing a patient's blood, separating it into its different components (such as plasma, platelets, and red blood cells), and then returning the desired components back into the patient's bloodstream. Apheresis is used to treat a variety of medical conditions, including autoimmune disorders, blood disorders, and neurological diseases.

The apheresis market refers to the global market for apheresis products and services, including equipment such as apheresis machines, disposables such as filters and tubing sets, and related services such as training and maintenance. The market includes both the therapeutic and donor apheresis segments. The therapeutic segment includes procedures performed on patients to treat medical conditions, while the donor segment includes procedures performed on healthy individuals to collect blood components for use in transfusions or other medical treatments.

The apheresis market has grown significantly in recent years, driven by factors such as the increasing prevalence of chronic diseases, technological advancements in apheresis equipment and procedures, and the growing demand for blood products. The market is expected to continue to grow in the coming years, with a particular emphasis on the therapeutic segment as new treatments and applications for apheresis are developed.

What is the outlook for Apheresis Market?

The outlook for the apheresis market is generally positive. The market is expected to continue to grow in the coming years, driven by a combination of factors such as increasing prevalence of chronic diseases, rising demand for blood products, technological advancements in apheresis equipment and procedures, and the development of new therapeutic applications for apheresis.

According to Market Research Engine, the global apheresis market is expected to grow at a compound annual growth rate (CAGR) of around 7% between 2021 and 2028. The therapeutic apheresis segment is expected to be the fastest-growing segment due to the increasing demand for apheresis procedures in the treatment of autoimmune diseases, neurological disorders, and cancer.

Moreover, the COVID-19 pandemic has further accelerated the growth of the apheresis market, as apheresis procedures have been used in the treatment of critically ill COVID-19 patients. The pandemic has also increased the demand for convalescent plasma, which is collected through apheresis.

Overall, the apheresis market is expected to continue to expand in the coming years, as apheresis becomes an increasingly important tool in the treatment of a wide range of medical conditions.

How Big is the Apheresis Market?

The global apheresis market size was valued at around USD 2.5 billion in 2020, according to market research reports. The market size is expected to reach around USD 4.2 billion by 2028, growing at a compound annual growth rate (CAGR) of around 7% between 2021 and 2028.

The market is segmented by product type, procedure type, technology type, application, and end-user. The product type segment includes apheresis machines, disposables, and software. The procedure type segment includes therapeutic apheresis and donor apheresis. The technology type segment includes centrifugation, membrane filtration, and other technologies. The application segment includes neurology, hematology, renal disorders, and others. The end-user segment includes hospitals and clinics, blood collection centers, and other end-users.

The therapeutic apheresis segment is expected to be the fastest-growing segment due to the increasing demand for apheresis procedures in the treatment of autoimmune diseases, neurological disorders, and cancer.

North America is the largest market for apheresis, followed by Europe, due to the high prevalence of chronic diseases, well-established healthcare infrastructure, and the presence of key players in these regions.

Overall, the apheresis market is expected to continue to grow in the coming years, driven by factors such as increasing prevalence of chronic diseases, technological advancements in apheresis equipment and procedures, and the development of new therapeutic applications for apheresis.

Apheresis Market Size, Share, Analysis

As mentioned earlier, the global apheresis market size was valued at around USD 2.5 billion in 2020 and is expected to reach around USD 4.2 billion by 2028, growing at a compound annual growth rate (CAGR) of around 7% between 2021 and 2028. The market is segmented by product type, procedure type, technology type, application, and end-user.

By product type, the apheresis market is segmented into apheresis machines, disposables, and software. Apheresis machines held the largest share of the market in 2020, as they are the key equipment used for apheresis procedures. However, the disposables segment is expected to grow at the highest CAGR during the forecast period due to the increasing demand for disposable apheresis kits and components.

By procedure type, the market is segmented into therapeutic apheresis and donor apheresis. Therapeutic apheresis held the largest share of the market in 2020, as it is used for the treatment of a wide range of medical conditions, including autoimmune diseases, neurological disorders, and cancer. Donor apheresis is used to collect blood components from healthy individuals for use in transfusions or other medical treatments.

By technology type, the market is segmented into centrifugation, membrane filtration, and other technologies. Centrifugation held the largest share of the market in 2020, as it is the most commonly used technology for apheresis procedures. However, membrane filtration is expected to grow at the highest CAGR during the forecast period due to its advantages such as higher safety and efficiency.

By application, the market is segmented into neurology, hematology, renal disorders, and others. Neurology held the largest share of the market in 2020, as apheresis is used in the treatment of neurological disorders such as multiple sclerosis and myasthenia gravis. However, the renal disorders segment is expected to grow at the highest CAGR during the forecast period due to the increasing prevalence of kidney diseases.

By end-user, the market is segmented into hospitals and clinics, blood collection centers, and other end-users. Hospitals and clinics held the largest share of the market in 2020, as they are the primary location where apheresis procedures are performed. However, the blood collection centers segment is expected to grow at the highest CAGR during the forecast period due to the increasing demand for blood products.

In summary, the apheresis market is expected to continue to grow in the coming years, driven by factors such as increasing prevalence of chronic diseases, technological advancements in apheresis equipment and procedures, and the development of new therapeutic applications for apheresis.

Browse further details of this market: https://www.marketresearchengine.com/apheresis-market